Bioequivalence Study of BAY77-1931 Granule

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Hyperphosphatemia

Interventions

DRUG

Lanthanum Carbonate (Fosrenol, BAY77-1931) Granule

BAY77-1931 Granule TID for 4 days

DRUG

Lanthanum Carbonate (Fosrenol, BAY77-1931) Chewable tablet

BAY77-1931 Chewable tablet TID for 4 days

Trial Locations (1)

Osaka